Mayank R. Mehta is a Professor at the University of California, Los Angeles (UCLA), holding joint appointments in the Departments of Physics & Astronomy, Neurology, and Neurobiology. He is a member of the Brain Research Institute and the W. M. Keck Center for Neurophysics at UCLA. His research bridges experimental and theoretical neuroscience, focusing on how neuronal networks encode space-time, the role of brain rhythms in learning and memory, and the impact of sleep and virtual reality on neural dynamics. His recent publications highlight breakthroughs in understanding hippocampal spatiotemporal selectivity, dendritic activity during behavior, and the causal influence of visual cues on memory neurons. Notable findings include the discovery that dendrites generate ten times more spikes than neuronal cell bodies and the modulation of hippocampal theta rhythms in virtual reality. Research Themes: Neurophysics of spatial-temporal coding Dendritic contributions to learning Virtual reality and brain plasticity Neural oscillations in memory consolidation Key Collaborators: Bert Sakmann (Max Planck Florida Institute) Thomas Hahn (Bernstein Center Heidelberg/Mannheim) Maryam Ghorbani (UCLA) Mehta's lab at UCLA trains graduate and postdoctoral researchers in cutting-edge techniques combining hardware development, electrophysiological recordings, and biophysical modeling. His work has significant implications for treating learning and memory disorders like Alzheimer's disease.
Jun Liu is a distinguished scientist and academic, serving as a Battelle Fellow at Pacific Northwest National Laboratory (PNNL) and holding the position of Campbell Chair Professor at the University of Washington. His career spans over three decades in materials science and energy storage research, with significant leadership roles including Director of the Battery500 Consortium, a major DOE initiative focused on developing next-generation battery technologies. Dr. Liu earned his Bachelor's degree in Chemical Engineering from Hunan University, followed by a Master's degree in Ceramic Engineering and a Ph.D. in Materials Science and Engineering, both from the University of Washington. His educational background provided the foundation for his extensive career in advanced materials development. Dr. Liu's research focuses on the development, synthesis, and characterization of new materials for energy applications, with particular emphasis on battery technologies. His work spans lithium-ion batteries, lithium-sulfur systems, redox flow batteries, and magnesium-based energy storage solutions. He has pioneered approaches to improve energy density, cycle life, and safety of battery systems through innovative materials design and interface engineering. Analysis of Dr. Liu's recent publications reveals a strong focus on practical battery applications, with particular attention to lithium metal anodes, solid electrolyte interphases, and high-energy battery systems. His research increasingly addresses the challenges of translating laboratory discoveries into commercially viable battery technologies, with growing emphasis on pouch cell development and real-world performance metrics. Distinguished Inventor of Battelle (2007) PNNL's Inventor of the Year (2012, 2016) Electrochemical Society Battery Division Technology Award DOE EERE Exceptional Achievement Award PNNL Lifetime Achievement Award Fellow of the American Association for the Advancement of Science Fellow of the Materials Research Society Member of the Washington State Academy of Science Dr. Liu has secured substantial research funding through his leadership of the Battery500 Consortium and other DOE initiatives. He has mentored numerous researchers and students throughout his career, contributing to the development of the next generation of energy storage scientists. His research group at PNNL collaborates extensively with academic institutions, national laboratories, and industry partners to advance battery technology. Dr. Liu leads the Battery500 Consortium, a major collaborative effort involving multiple national laboratories, universities, and industry partners focused on developing lithium-metal batteries with significantly higher energy density than current technologies. His research group at PNNL maintains state-of-the-art facilities for materials synthesis, characterization, and battery testing, enabling comprehensive investigation of next-generation energy storage systems.
Judith Driscoll is Professor of Materials Science at the University of Cambridge in the Department of Materials Science & Metallurgy. She holds the prestigious Royal Academy of Engineering Chair in Emerging Technologies and serves as a Visiting Staff Member at Los Alamos National Laboratory. As the founding Editor-in-Chief of APL Materials, she has significantly contributed to the materials science community. Dr. Driscoll's research focuses on Energy Efficient Oxide Materials for Information and Communications Technologies and energy devices. Her work spans the development of non-volatile memory, resistive switching devices, and ferroelectric materials for neuromorphic computing applications. She investigates oxide thin films for applications ranging from data storage to energy generation and conversion, with particular emphasis on creating more energy-efficient device technologies to handle the exponential growth of data-centric applications. Her recent publications demonstrate strong trends in developing novel oxide-based memory devices with improved energy efficiency, particularly for AI applications. The work shows significant progress in hafnium-zirconium oxide ferroelectrics, resistive switching mechanisms, and vertically aligned nanocomposite structures for enhanced device performance. These innovations address critical challenges in reducing the unsustainable energy demands of modern computing, particularly for artificial intelligence systems. Fellow of the Royal Academy of Engineering Fellow of the Materials Research Society Fellow of the American Physical Society Fellow of IOM3, IOP, and Women Engineers Society Fellow of the American Academy of Arts and Sciences Recipient of ERC Advanced Grant Editor-in-Chief of APL Materials Dr. Driscoll leads a vibrant research group that has secured significant funding including her Royal Academy of Engineering Research Chair, an ERC Advanced Grant, and an ECCS-EPSRC grant in collaboration with researchers from the USA. She has founded the Cambridge Centre for Neuromorphic Computing (Neucam) in 2023. Her group operates world-leading growth equipment including pulsed laser deposition with RHEED control, high temperature oxide sputtering, and spatial ALD systems. She collaborates extensively across the University of Cambridge and with international partners to solve complex materials challenges, with her group's role often being to identify optimal materials for functional goals, predict fabrication methods, and then create and characterize these materials.
Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.
Prof Terry O'Neill serves as Executive Dean at the Bond Business School , Bond University, while also holding the title of Professor and Director at the Centre for Data Analytics. His research spans applied statistics , big data analytics , and financial modeling , with over 80 publications (20% in A* journals). Grants: Lead investigator on five ARC Discovery/Linkage grants totaling $2.99M, including studies on retirement savings, climate change modeling, and financial crisis resilience. Research Trends: Focus on financial literacy , retirement economics , and myelopoiesis , bridging finance with computational biology through collaborations with his spouse Helen O'Neill. Academic Leadership: Established Bond University's University Centre in Actuarial and Financial Big Data Analytics to elevate institutional research prominence in data science.
Prof. Waldemar Kolanus leads the Molecular Immunology and Cell Biology department at the University of Bonn's Life & Medical Sciences Institute (LIMES) . His research bridges immunoregulation , stem cell dynamics , and metabolic stress responses in immune cells. Unit 2 member at LIMES Principal investigator in SFB 704 and ImmunoSensation Cluster Leads a multidisciplinary lab with postdocs, PhD students, and technical staff His work focuses on intracellular signaling pathways connecting immune activation to tissue homeostasis, particularly through: Cytohesin proteins in integrin-mediated adhesion and migration TRIM71 in stem cell regulation and congenital hydrocephalus High-salt environments affecting macrophage function Publication trends show expertise in immune cell migration , genetic models , and chemical inhibition , with frequent use of mice and zebrafish for in vivo studies. Key articles explore: TRIM71's dual role in auditory development and germ cell maintenance Cytohesin family's Golgi regulation and insulin signaling Ruxolitinib's off-target migration inhibition of dendritic cells Contact details: Address: LIMES Institute, Carl-Troll-Straße 31, Bonn Email: kolanus.sekretariat@uni-bonn.de Phone: +49 228 73-62788
Zhiling Gu is a Research Fellow at Yale School of Public Health, having earned her Ph.D. in Statistics at Iowa State University. Her work integrates statistical theory with applications in public health and medicine. Her research spans Functional Data Analysis Network Analysis Spatiotemporal Modeling Statistical AI Foundations Nonparametric Learning applied to neuroimaging, electronic health records, and environmental health studies. Recent publications focus on Adaptive spatiotemporal models Neuroimaging data processing Pandemic forecasting frameworks Environmental exposure modeling with methodological rigor and practical implementation. Scientific achievements include Runner-up in SMI 2023 Student Paper Competition She has taught STAT 305: Engineering Statistics (ISU) STAT 226: Business Statistics Statistical Computing Statistical Learning and actively engages in academic presentations at conferences like SMI 2024 and CMStatistics 2022.
Konstantinos Anastassiadis is a Professor at the Center for Molecular and Cellular Bioengineering (CMCB) of Dresden University of Technology , leading the Stem Cell Engineering group at the Biotechnology Center (BIOTEC) . His research focuses on unraveling molecular pathways regulating stem cell self-renewal and lineage commitment, with a strong emphasis on genetic engineering tool development and epigenetic mechanisms during cellular reprogramming. The lab utilizes mouse and human embryonic stem cells, neural stem cells, mesenchymal stromal cells, and induced pluripotent stem cells (iPSCs) in their investigations. Core Research Areas: Molecular regulation of stem cell fate Epigenetic mechanisms (e.g., UTX/UTY histone demethylases) Genetic engineering tool development (Flp, Dre, Vika recombinases, CRISPR protocols) Conditional immortalization systems for rare cell expansion Publications highlight his contributions to understanding: Role of histone methyltransferases (MLL1, MLL2, Setd1b) in hematopoiesis and cancer Epigenetic regulation during mouse development and spermatogenesis Genetic tools for protein tagging, transposon-mediated BAC transgenesis Interactions between stem cells and niche microenvironments Transcriptional and mechanical markers during reprogramming Collaborations span immunology , developmental biology , and bioinformatics . The lab actively participates in teaching activities at CMCB and maintains a focus on translational applications of stem cell research.
Dr. Julie N.L. Albert is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at Tulane University, holding the Robert and Gayle Longmire Early Career Professorship. She is affiliated with the School of Science and Engineering and serves as co-director of the SMART REU NSF-funded program. Her research focuses on engineering nano- and micro-structured polymeric materials for energy, health, and environmental applications, emphasizing self-assembly processes in block copolymers and polymer blends. Key areas include nanoporous membranes, biocompatible surfaces, and stimuli-responsive materials. Dr. Albert earned her B.S. in Chemical Engineering from the University of Florida (2005) and her Ph.D. from the University of Delaware (2012). She conducted postdoctoral research at North Carolina State University. Her work has been supported by prestigious grants, including the NSF CAREER Award and a Gulf Research Program Fellowship. Her research group explores topics like polymer crystallization, polyorganosiloxanes, and block copolymer architectures. Notable achievements include developing methods for controlling polymer morphology via solvent vapor annealing and surface chemistry gradients. She advises numerous graduate and undergraduate students and mentors organizations like the Society of Women Engineers. Education: B.S., Chemical Engineering, University of Florida, 2005 Ph.D., Chemical Engineering, University of Delaware, 2012 Research Interests: Self-assembly of block copolymers, nanoporous membranes, biocompatible materials, and energy applications. Awards: NSF Graduate Research Fellowship, Gulf Research Program Early-Career Fellowship, AIChE Travel Award. Dr. Albert’s lab houses advanced facilities such as AFM, spectral reflectometry, and GPC, enabling cutting-edge polymer characterization. Her contributions bridge polymer science, materials engineering, and environmental sustainability, addressing challenges in energy recovery and biomedical technologies.
Laura Solt, Ph.D. is an Associate Professor in the Department of Immunology and Microbiology at the Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter, Florida. She also serves as Associate Dean of the Skaggs Graduate School of Chemical and Biological Sciences. Dr. Solt began her independent research career at Scripps Florida in 2013 and has established herself as a leading researcher in nuclear receptor biology within the immune system. Her research focuses on understanding the biologically relevant roles of nuclear receptors, particularly RORα and REV-ERBs, in the immune system with emphasis on TH17 cell development and autoimmune disease. Her lab employs a multidisciplinary approach combining molecular biology, genetic techniques, and chemical biology coupled with mouse models of autoimmunity and chronic inflammation. Dr. Solt's laboratory has made significant contributions to understanding how nuclear receptors regulate immune cell function, particularly in TH17-mediated inflammation. Her work has demonstrated roles for RORα and REV-ERBs in TH17 cell development and has developed synthetic ligands to these receptors for potential therapeutic applications in autoimmune diseases. Her extensive publication record shows a clear trajectory of research focused on nuclear receptor signaling in immunity, with recent work expanding into applications for cancer immunotherapy, neuroimmunology, and metabolic aspects of immune cell function. Her articles demonstrate expertise in both basic nuclear receptor mechanisms and translational applications. Ruth L. Kirschstein National Research Service Awards (2010-2013) Dr. Solt actively mentors graduate students including Adrianna Wilson (recipient of NIDDK F31 and Scheller Graduate Student Fellowship) and Sarah Mosure (recipient of NIH NRSA F31 award and Wendy Havran award). Her laboratory receives substantial funding from multiple NIH institutes (NIDDK, NCI, NIAID, NIGMS) as well as the Crohn's & Colitis Foundation. Current research directions include investigating the roles of NR2F6 in TH17 cells, exploring RORα function in CD8 T cells, and developing novel nuclear receptor modulators for therapeutic applications.
Santiago F. González is a Group Leader at the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, and an extraordinary professor at the University of Italian Switzerland (USI). He earned dual PhDs in microbiology (University of Santiago de Compostela, Spain) and immunology (University of Copenhagen, Denmark), followed by postdoctoral work (2007–2011) at Harvard Medical School's Immune Disease Institute under Michael Carroll. PhD in Microbiology, University of Santiago de Compostela PhD in Immunology, University of Copenhagen His research focuses on immune system dynamics during respiratory viral infections, vaccination, and cancer metastasis. Key areas include influenza recognition , lymph node inflammation , and immune cell behavior in vivo. He pioneered studies on C-type lectin receptors (e.g., SIGN-R1) in viral immunity and epigenetic modulators for inflammation. Recent publications highlight his work in epigenetic drug development , nanovaccines , and computational tools for immune cell tracking. His group uses two-photon intravital microscopy and spatial-temporal modeling to dissect immune responses. Scientific awards include three EU Marie Curie Fellowships (2004–2013), enabling his transition to independent research. His collaborations span Harvard, USI, and European institutions, with grants from the EU and Swiss research bodies. His lab at IRB, established via the 2013 Marie Curie Career Integration Grant , develops novel imaging approaches and therapeutic strategies for infectious and immune-mediated diseases.
Lisa Westerberg is a Professor of Experimental Immunology at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet. Her research focuses on understanding how compromised immune systems lead to immunodeficiency, autoimmunity, and hematological cancers, particularly studying the role of actin regulators in immune cell function. She leads the 'Immunodeficiency Diseases – Lisa Westerberg Group' and collaborates internationally with institutions like Harvard Medical School and the University College London. Education: PhD in Cell and Molecular Biology from Karolinska Institutet (2003), postdoc at Harvard Medical School (2009). Affiliations: Department of Microbiology, Tumor and Cell Biology; WASPSTINGS network (STINT-funded); Swedish Society for Immunology (Treasurer). Research Interests: Immunodeficiency diseases, actin cytoskeleton dynamics in immune cells, cancer immunology, and space immunology. Her lab investigates how genetic mutations in actin regulators affect immune cell communication, migration, and genomic stability. Recent projects include studying immune system adaptation in microgravity and developing therapies targeting actin regulators in cancer. Articles Trends: Recent work highlights immune cell adaptations in space environments, therapeutic modulation of actin pathways, and clonal evolution in lymphomas. Over 15 articles since 2020 explore mechanisms linking immune dysfunction to cancer and immunodeficiency. Awards: Ragnar Söderberg Fellowship, ERC Starting Grant (2019), Wallenberg Academy Fellow. Funding: Swedish Research Council, Knut och Alice Wallenberg Foundation, EU grants. Advising & Grants: Supervised over 40 students (PhD, Master’s, undergrad) since 2010. Active in training programs like the Amgen Scholars initiative. Collaborates with global teams on projects funded by VR, NIH, and international partnerships. Labs/Teams: Leads the core Immunodeficiency Diseases Group and collaborates with the Dosenovic Lab (focusing on B cell vaccine development). The group uses CRISPR, high-resolution microscopy, and single-cell sequencing to study immune mechanisms.
Juliane Nguyen, PhD, is a Professor in the Department of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill. She serves as Vice Chair and Director of Graduate Admissions in her department and holds an adjunct appointment as Professor of Biomedical Engineering. Dr. Nguyen is also a member of the UNC Lineberger Comprehensive Cancer Center, where she applies molecular engineering approaches to develop innovative therapeutic solutions. Dr. Nguyen's research focuses on molecular engineering to advance protein-based therapeutics, live biotherapeutics (including engineered probiotic yeast), and extracellular vesicles. Her lab develops cutting-edge technologies to treat diverse conditions including cancer, myocardial infarction, chemotherapy-induced cardiotoxicity, and inflammatory bowel diseases. Her interdisciplinary approach integrates molecular engineering, pharmaceutical sciences, and bioinformatics to create complex biologics with exceptional safety and efficacy profiles. Key research areas include developing therapeutics for cardiac repair, genetically encoded materials targeting tumor-associated macrophages, live biotherapeutics for inflammatory bowel diseases using engineered probiotic yeast, and auxetic patches for dynamic organ repair. Analysis of Dr. Nguyen's recent publications reveals a strong focus on translational research with significant contributions to cardiac repair technologies, cancer immunotherapy, inflammatory bowel disease treatments, and advanced biomaterials. Her work consistently bridges fundamental molecular engineering with clinical applications, particularly in the areas of targeted drug delivery, extracellular vesicle therapeutics, and engineered live biotherapeutics. The research demonstrates a clear trajectory toward developing clinically viable solutions for previously challenging medical conditions. Dr. Nguyen has received numerous prestigious awards and honors including the NSF CAREER Award (2018), Eshelman Innovation Award (2020), and recognition as a Fellow of the Controlled Release Society (2023). She was appointed as a Standing Member of the NIH Drug and Biologic Therapeutic Delivery Study Section (2023-2025) and serves as Executive Editor of Advanced Drug Delivery Reviews since 2021. Her Galenus Guest Professorship at ETH Zuerich (2024) and keynotes at major conferences highlight her international recognition in the field. As Director of Graduate Admissions and an active mentor, Dr. Nguyen has advised numerous PhD and Master's students who have co-authored significant publications with her. Her research is supported by competitive grants including the NSF CAREER Award and other NIH-funded projects. The Nguyen Lab maintains strong collaborations across disciplines, particularly with cardiology, oncology, and biomedical engineering researchers. She leads an interdisciplinary team focused on translating molecular engineering breakthroughs into clinically impactful therapies. The Nguyen Lab operates as a dynamic, interdisciplinary research environment combining expertise in molecular engineering, pharmaceutical sciences, and bioinformatics. The lab's mission is to revolutionize medicine by developing next-generation therapeutics that target diseases at the molecular level. Current projects focus on translating cutting-edge research into life-changing therapies for patients suffering from cancer, myocardial infarction, colitis, and other challenging conditions. The lab's innovative approach to biomolecular engineering positions it at the forefront of developing safe, effective, and personalized therapeutic solutions.
Caetano Reis e Sousa is a Professor of Immunology at Imperial College London and Senior Group Leader/Assistant Research Director at the Francis Crick Institute. He leads the Immunobiology Laboratory, focusing on dendritic cell biology, immune responses to pathogens, and cancer immunotherapy. His research explores how dendritic cells detect pathogens and dying cells, triggering adaptive immunity. Key roles include investigating cross-presentation mechanisms, C-type lectin receptors (e.g., DNGR-1), and vaccine development strategies. Education: BSc (Hons) Biology from Imperial College London (1989), DPhil in Immunology from University of Oxford (1992). Postdoctoral training at NIH under Ron Germain. Career milestones include founding the Immunobiology Lab at CRUK London Research Institute (1998–2015) before joining the Crick. Awards & Recognition: Highly Cited Researcher (Thomson Reuters), BD Biosciences Prize (2002), Liliane Bettencourt Award (2008), Louis-Jeantet Prize (2017), Fellowships at Royal Society (2019), Academy of Medical Sciences (2006), and EMBO (2006). Named Officer of the Order of Sant'Iago da Espada (Portugal, 2009). Research Themes: Dendritic cell activation pathways, cross-presentation of tumor antigens, microbiome-cancer immunity links, and immune evasion mechanisms. Collaborations involve institutions like UCL, King's College London, and global health networks. Labs/Teams: Head of Immunobiology Lab at Crick, with expertise in immunology, cell biology, and virology. Facilities include Flow Cytometry, Genomics, and Light Microscopy cores. Active in pandemic response (e.g., SARS-CoV-2 testing initiatives).
Prof. Friederike Ebner holds the Chair of Infection Pathogenesis at the Technical University of Munich (TUM) since 2023, within the TUM School of Life Sciences. Her research focuses on the immunobiology of parasite infections, particularly studying gastrointestinal helminths like Ascaris suum and their interactions with host immune systems to design novel intervention strategies. She also develops biomedical models for studying infectious diseases. Educational Background: Friederike Ebner earned a biotechnology degree from TU Berlin and Dongseo University (South Korea). She completed her PhD in biology at Humboldt University Berlin (2014), followed by postdoctoral research in immunology at Freie Universität Berlin, where she became an assistant professor before moving to TUM. Research Interests: Her work spans helminth-host immune dynamics, vaccine development, microbiome interactions in parasitic infections, and translational models for human diseases. Key topics include Th2/Th1 immune balance, helminth-derived immunomodulators, and xenotransplantation safety. Notable Contributions: Her recent studies address diagnostic methods for ascariasis, microbiome roles in helminth survival, and immunotherapeutic applications of parasite products. Current efforts emphasize bridging fundamental immunology with clinical and veterinary applications. Professional Activities: Prof. Ebner teaches immunology and parasite biology at TUM while maintaining active collaborations in global health and infectious disease research. She advocates for interdisciplinary approaches to address knowledge gaps in parasitology and vaccinology.
